SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported)       July 6, 1997
                                                 ----------------------


                        INTEGRATED HEALTH SERVICES, INC.
--------------------------------------------------------------------------------
               (Exact Name of Registrant as Specified in Charter)

       Delaware                  1-12306                    23-2428312
(State or Other Jurisdiction   (Commission                   (IRS Employer
     of Incorporation)         File Number)               Identification No.)

 10065 Red Run Boulevard, Owings Mills, Maryland                      21117
-------------------------------------------------                    ----------
(Address of Principal Executive Offices)                             (Zip Code)

Registrant's telephone number, including area code:       (410) 998-8400

                                 Not Applicable
--------------------------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)


<PAGE>




ITEM 5.  OTHER EVENTS

         On  July  6,  1997,  Integrated  Health  Services,  Inc.  ("IHS"),  IHS
Acquisition  XXIV,  Inc., a wholly-owned  subsidiary of IHS ("Merger Sub"),  and
RoTech Medical  Corporation  ("RoTech") entered into a definitive  agreement and
plan of merger  (the  "Agreement")  providing  for the merger of Merger Sub into
RoTech,  with RoTech becoming a wholly-owned  subsidiary of IHS. RoTech provides
comprehensive home healthcare and primary care physician  services,  principally
to patients in non-urban  areas.  RoTech's home healthcare  business  provides a
diversified  range of products and services,  with emphasis on  respiratory  and
home infusion services. RoTech currently operates over 600 home health locations
and approximately 26 primary care physicians  practices. 

         Under the terms of the  Agreement,  which was  approved by the Board of
Directors of both IHS and RoTech, holders of RoTech common stock ("RoTech Common
Stock") will receive for each share of RoTech  Common Stock 0.5806 of a share of
IHS Common Stock (the "Exchange  Ratio"),  having a market value of $22.61 based
on the closing  price of the IHS Common Stock on the last  business day prior to
the signing of the  Agreement.  Options to purchase  RoTech Common Stock will be
converted  at the closing into options to purchase IHS Common Stock based on the
Exchange  Ratio. At June 30, 1997 RoTech had  outstanding  26,362,269  shares of
RoTech  Common Stock and options to purchase  3,469,706  shares of RoTech Common
Stock ("RoTech Options").  IHS will issue approximately 15,306,000 shares of IHS
Common Stock under the  Agreement,  and will reserve for issuance  approximately
2,014,000  shares of IHS Common Stock issuable upon exercise of RoTech  Options.
In  addition,  RoTech's  outstanding  $110 million of  subordinated  convertible
debentures (the "RoTech  Debentures") will become convertible into approximately
2,433,000 shares of IHS Common Stock following the closing at a conversion price
of $45.21 per share of IHS Common Stock.  At June 30, 1997, IHS had  outstanding
25,428,319  shares of IHS Common  Stock and  options  and  warrants  to purchase
approximately  9,513,000  shares  of IHS  Common  Stock,  and had  reserved  for
issuance  7,989,275  shares upon conversion of $258,750,000  principal amount of
outstanding convertible  debentures.  IHS will assume approximately $300 million
of debt in the transaction, including $110 million of the RoTech Debentures.

         The merger is  intended  to qualify  as a tax free  reorganization,  as
permitted by the Internal  Revenue  Code,  and will be treated as a purchase for
accounting  and financial  reporting  purposes.  Completion of the  transaction,
which is expected to occur in the fourth quarter of 1997,  is subject to,  among
other  things,  approval  by each  company's  stockholders,  receipt of required
regulatory  approvals,  consent  of senior  bank  lenders  and  other  customary
conditions.  Each party may terminate the Agreement if the average trading price
of the IHS Common Stock over the 10 trading days ending on the fifth trading day
prior to the RoTech  stockholders  meeting  to  approve  the merger is less than
$33.00.  The  Agreement  also  provides  for the payment of break-up  fees under
certain circumstances.

         Donaldson Lufkin & Jenrette  Securities  Corporation acted as financial
advisor to IHS in the transaction.

                                       2

<PAGE>

ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

         (C)  EXHIBITS.

          2    Agreement  and Plan of Merger  entered  into as of July 6,  1997,
               among  Integrated  Health Services,  Inc., IHS Acquisition  XXIV,
               Inc. and RoTech Medical Corporation.







                                       3

<PAGE>




                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                           INTEGRATED HEALTH SERVICES, INC.

Date: July 10, 1997                        By: /s/ W. Bradley Bennett
                                               ----------------------
                                               Name: W. Bradley Bennett
                                               Title: Executive Vice President -
                                                        Chief Accounting Officer
[{"type": "8-K", "sequence": "1", "description": "FORM 8-K", "secsgml_size_bytes": 5985}]
{"company-data": {"conformed-name": "INTEGRATED HEALTH SERVICES INC", "cik": "0000785814", "assigned-sic": "8051", "irs-number": "232428312", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-12306", "film-number": "97639300"}, "business-address": {"street1": "10065 RED RUN BLVD", "city": "OWINGS MILLS", "state": "MD", "zip": "21117", "phone": "4109988400"}, "mail-address": {"street1": "100065 RED RUN BLVD", "city": "OWINGS MILLS", "state": "MD", "zip": "21117"}}
SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported)       July 6, 1997
                                                 ----------------------

                        INTEGRATED HEALTH SERVICES, INC.
--------------------------------------------------------------------------------
               (Exact Name of Registrant as Specified in Charter)

       Delaware                  1-12306                    23-2428312
(State or Other Jurisdiction   (Commission                   (IRS Employer
     of Incorporation)         File Number)               Identification No.)

 10065 Red Run Boulevard, Owings Mills, Maryland                      21117
-------------------------------------------------                    ----------
(Address of Principal Executive Offices)                             (Zip Code)

Registrant's telephone number, including area code:       (410) 998-8400

                                 Not Applicable
--------------------------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)
ITEM 5.  OTHER EVENTS

         On  July  6,  1997,  Integrated  Health  Services,  Inc.  ("IHS"),  IHS
Acquisition  XXIV,  Inc., a wholly-owned  subsidiary of IHS ("Merger Sub"),  and
RoTech Medical  Corporation  ("RoTech") entered into a definitive  agreement and
plan of merger  (the  "Agreement")  providing  for the merger of Merger Sub into
RoTech,  with RoTech becoming a wholly-owned  subsidiary of IHS. RoTech provides
comprehensive home healthcare and primary care physician  services,  principally
to patients in non-urban  areas.  RoTech's home healthcare  business  provides a
diversified  range of products and services,  with emphasis on  respiratory  and
home infusion services. RoTech currently operates over 600 home health locations
and approximately 26 primary care physicians  practices. 

         Under the terms of the  Agreement,  which was  approved by the Board of
Directors of both IHS and RoTech, holders of RoTech common stock ("RoTech Common
Stock") will receive for each share of RoTech  Common Stock 0.5806 of a share of
IHS Common Stock (the "Exchange  Ratio"),  having a market value of $22.61 based
on the closing  price of the IHS Common Stock on the last  business day prior to
the signing of the  Agreement.  Options to purchase  RoTech Common Stock will be
converted  at the closing into options to purchase IHS Common Stock based on the
Exchange  Ratio. At June 30, 1997 RoTech had  outstanding  26,362,269  shares of
RoTech  Common Stock and options to purchase  3,469,706  shares of RoTech Common
Stock ("RoTech Options").  IHS will issue approximately 15,306,000 shares of IHS
Common Stock under the  Agreement,  and will reserve for issuance  approximately
2,014,000  shares of IHS Common Stock issuable upon exercise of RoTech  Options.
In  addition,  RoTech's  outstanding  $110 million of  subordinated  convertible
debentures (the "RoTech  Debentures") will become convertible into approximately
2,433,000 shares of IHS Common Stock following the closing at a conversion price
of $45.21 per share of IHS Common Stock.  At June 30, 1997, IHS had  outstanding
25,428,319  shares of IHS Common  Stock and  options  and  warrants  to purchase
approximately  9,513,000  shares  of IHS  Common  Stock,  and had  reserved  for
issuance  7,989,275  shares upon conversion of $258,750,000  principal amount of
outstanding convertible  debentures.  IHS will assume approximately $300 million
of debt in the transaction, including $110 million of the RoTech Debentures.

         The merger is  intended  to qualify  as a tax free  reorganization,  as
permitted by the Internal  Revenue  Code,  and will be treated as a purchase for
accounting  and financial  reporting  purposes.  Completion of the  transaction,
which is expected to occur in the fourth quarter of 1997,  is subject to,  among
other  things,  approval  by each  company's  stockholders,  receipt of required
regulatory  approvals,  consent  of senior  bank  lenders  and  other  customary
conditions.  Each party may terminate the Agreement if the average trading price
of the IHS Common Stock over the 10 trading days ending on the fifth trading day
prior to the RoTech  stockholders  meeting  to  approve  the merger is less than
$33.00.  The  Agreement  also  provides  for the payment of break-up  fees under
certain circumstances.

         Donaldson Lufkin & Jenrette  Securities  Corporation acted as financial
advisor to IHS in the transaction.

                                       2
ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

         (C)  EXHIBITS.

          2    Agreement  and Plan of Merger  entered  into as of July 6,  1997,
               among  Integrated  Health Services,  Inc., IHS Acquisition  XXIV,
               Inc. and RoTech Medical Corporation.

                                       3
SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                           INTEGRATED HEALTH SERVICES, INC.

Date: July 10, 1997                        By: /s/ W. Bradley Bennett
                                               ----------------------
                                               Name: W. Bradley Bennett
                                               Title: Executive Vice President -
                                                        Chief Accounting Officer